What is the main therapeutic approach in acute ischemic stroke?

The primary therapeutic approach in acute ischemic stroke is reperfusion therapy, which utilizes thrombolytics or thrombectomy procedures. This strategy is aimed at restoring blood flow to the brain as quickly as possible after an ischemic event occurs, which is crucial because brain cells begin to die rapidly without adequate blood supply.

Thrombolytics, such as tissue plasminogen activator (tPA), are medications that dissolve blood clots blocking the arteries, thereby allowing for the restoration of circulation and minimizing the extent of brain damage. Thrombectomy is a mechanical procedure where specialists physically remove the clot from the blood vessel, providing an alternative approach when thrombolytics are not suitable or effective.

This timely intervention is essential to improve functional outcomes and reduce long-term disabilities associated with strokes. The success of reperfusion therapies significantly decreases the mortality rate and enhances recovery prospects in patients affected by ischemic strokes, making it the cornerstone of acute stroke management.

Surgical interventions, corticosteroids, and behavioral therapies do not play a primary role in the immediate management of acute ischemic stroke and therefore do not represent the main therapeutic approach in these critical situations.